
This case study of a 21-year-old woman-referred by a relative because of long-standing severe interpersonal, academic, and occupational impairment-illustrates the importance of screening patients with brief episodes of depression for mixed features.

This case study of a 21-year-old woman-referred by a relative because of long-standing severe interpersonal, academic, and occupational impairment-illustrates the importance of screening patients with brief episodes of depression for mixed features.

A look into longer-term clinical and psychosocial outcomes of depressive disorder in early adulthood, as well as clinical and demographic variables associated with recurrence and lack of remission.

Catatonia-a syndrome of disturbed motor, mood, and systemic signs (eg, rigidity, immobility, mutism, staring, posturing, waxy flexibility, echopraxia, echolalia, and stereotypies)-has led to the clarification of its appropriate treatment.

This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.

In the opinion of this psychiatrist, the point of the MOC test isn’t to measure competence, but to convey the impression that competence was measured. The point of the test is to say that a test was given-and nothing else. More in this commentary.

In this CME article, the focus is on the significance of metabolic changes that develop during antipsychotic treatment, as well as on strategies to incorporate metabolic monitoring into clinical practice.

Do children with manic symptoms continue to experience mania? How common are suicidal ideation and attempts in bipolar youth? How severe is bipolar depression in children and adolescents? Answers to these and other questions from recent studies here. . .

Here: a succinct review of some of the potential promises and pitfalls of DSM-5.

A recent systematic review and meta-analysis that compared benzodiazepines with antidepressants for anxiety disorders has triggered a debate among clinicians about first-line treatments, efficacy for specific disorders, and adverse effects.

"The main problem here is not that past DSM leaders were derelict or purely political. The problem is that they now say that they would place science below pragmatism," according to this clinician.

The relationship between bipolar disorder and ADHD remains unclear; however, this combined condition may represent an important genetic and clinical subtype with distinct psychopathology, familiality, and treatment response.

According to the author, stimulant drugs that 20 years ago had annual revenues in the tens of millions now are a Pharma "cash cow" with sales that will soon hit $10 billion per year. How did this happen?

The controversy around marketing practices for ADHD.

Five key events in 2013 will leave a longlasting mark on psychiatry. Here: a look at the impact that CPT coding, DSM-5, sunshine laws, a shrinking market for “shrinks,” and I-STOP are likely to have on our field.

In the first of a two-part Special Report, the evaluation and management of psychosis is explored across a range of disorders and clinical contexts.

The first generation of cognitive-behavioral therapy for psychosis, when added to standard care, has demonstrated efficacy in treating patients with delusions and hallucinations. Details in this article.

Information from studies on adolescents with psychosis and a review of the evidence about the risk of suicide and suicidal behavior in this patient population.

While I watch the artist paint, I imagine him in the time of plague crafting a portrait of a Medico della Peste, a Plague Doctor wearing an ibis-like mask...

As the accolades roll in for Nelson Mandela on his death, lost among his astonishing accomplishments may be his relevance to mental health.

ADHD is on the rise according to a new report from the CDC, and most youngsters with the diagnosis are receiving treatment for the disorder. But the report raises a number of clinical implications . . .

As practicing physicians, we constantly ask ourselves when and where to alert patients to bad possibilities that may occur in the future. More in this installment of "Why Psychiatrist Are Physicians First," by Sharon Packer, MD.

A stalker may approach or follow the victim, or keep their residence under surveillance, setting up a perpetual cycle of fear for the victim and frustration or anger for the perpetrator. Here, subtypes of stalkers to determine which type of behavior his or her communications suggest.

"Psychosis Risk" can now be diagnosed as “Attenuated Psychosis Syndrome” and used to bill for insurance reimbursement. Many bearing the diagnostic label are young adolescents and adults in whom schizophrenia or any other psychotic disorder will never develop.

We know so little about community grieving. What is normal and what is not? Perhaps the tragedy in Newtown needs a careful analysis over time.

I have often wondered: did any of Parkland's sets of medical eyes experience a moment of stillness with the collective father who had just been declared dead? I readily acknowledge the difficulty with great humility.

One might expect that treating nicotine use would be a leading priority for physicians. The reality is that this is not the case. More in this expert commentary, with practical tips for clinicians.

Stopping smoking affects the metabolism of a number of drugs used in the management of mental illness. Here, a summary of the author's published study on whether e-cigarettes with nicotine were more effective for smoking cessation than nicotine patches.

Smoking is the leading cause of preventable morbidity and mortality in the US. The majority of smokers want to quit, but only a fraction achieve this annually. New evidence shows it is possible to teach patients to weaken the link between craving and smoking until they are able to ride out any craving–and consequently quit.

What percentage of patients with schizophrenia have a comorbid cannabis use disorder? Take the quiz and learn more.

In this brief video, Psychiatric Times’ new Editoral Board member talks about what DSM-5, the medical home, and the search for money to fund novel approaches to new psychiatric treatments may mean to the practice of psychiatry.